Pharmaceutical composition for treatment of neurodegenerative brain disease comprising rifamycin or pharmacurically acceptable salt thereof as an active ingredient
김성묵,김영수,신지수,전한나,이동희,김혜주,김고은,KIM SEONG MUK,KIM YOUNG SOO,SHIN JI SU,JEON HAN NA,LEE DONG HEE,KIM HYE JU,KIM KO EUN
申请号：
KR1020190152592
公开号：
KR1020817850000B1
申请日:
2019.11.25
申请国别(地区):
KR
年份:
2020
代理人:
摘要：
Novel pharmaceutical compositions and methods are provided for inhibiting amyloid aggregation and / or degradation, and / or inhibiting tau degradation and / or tau phosphorylation, and / or preventing and / or treating degenerative brain diseases.아밀로이드 응집 억제 및/또는 분해, 및/또는 타우 분해 및/또는 타우 인산화 억제, 및/또는 퇴행성 뇌질환의 예방 및/또는 치료를 위한 신규한 약학적 조성물 및 방법이 제공된다.
